PRTA — PROTHENA CORP PUBLIC LTD CO

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1559053 ·
Last close
$8.26
Market Cap
$424.15M
52W High
$11.80
52W Low
$7.70
ADV30
497,297
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 620,000 — -18,401,000 -16,509,000 283,520,000 271,368,000 14,683,000
Jun 2026 1,010,000 — -18,687,000 -18,583,000 302,579,000 288,193,000 15,688,000
Mar 2026 51,084,000 — 25,791,000 32,721,000 349,894,000 329,462,000 37,278,000
Dec 2025 21,000 — -27,211,000 -21,589,000 326,804,000 307,531,000 46,330,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-60,049,000
Investing CF
$-662,000
Financing CF
$-22,531,000
CapEx
$-138,000
Dividends Paid
—
Buybacks
$-22,531,000
EPS Diluted TTM
$-0.84
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,332,295,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-59,868,000
Pretax Income TTM
$-44,350,000
Interest Exp TTM
—
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$52,735,000
EBITDA
$-37,700,000
Free Cash Flow
$-19,837,500
Enterprise Value
$144,145,872
Total Cash
$271,368,000
Total Debt
$6,256,000
Shares Out
51,349,796
Trailing EPS
$-0.45
Book Value
$5.24
ROE
-8.5%
ROA
-7.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 9,684,000 -184,560,000 -244,092,000 326,804,000 46,330,000 280,474,000 -163,580,000
Dec 2024 135,157,000 -154,561,000 -122,310,000 547,108,000 60,182,000 486,926,000 -150,050,000
Dec 2023 91,370,000 -191,036,000 -147,028,000 696,382,000 135,017,000 561,365,000 -133,906,000
Dec 2022 53,905,000 -131,557,000 -116,949,000 758,035,000 135,993,000 622,042,000 -108,821,000

TTM Snapshot

Revenues TTM
$54,530,000
NetIncome TTM
$-43,992,000
OpCashFlow TTM
—
Assets (Latest)
$302,579,000
Forward EPS
$-1.31

Max Pain — expiry 2026-12-18

max pain strike: $9.00 · spot: $8.35 · call oi: 3,780 · put oi: 2,200
Expected Move to 2026-12-18: ±$1.76 (21.08%) — implied range $6.59 – $10.11 · ATM straddle on $8.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CTMX CytomX Therapeutics, Inc. $422.93M $1.94 —
OVID Ovid Therapeutics Inc. $418.98M $2.22 —
OCS Oculis Holding AG $417.01M $7.51 —
AVTX Avalo Therapeutics, Inc. $412.28M $7.13 —
EPRX EUPRAXIA PHARMACEUTICALS INC. $437.41M $6.62 —

News headlines (Yahoo Finance, 1h cache)

Insider Buying Signals: 3 Healthcare Stocks to Watch
2026-11-11 15:35 · Yahoo
Wall Street Analysts See a 120.16% Upside in Prothena (PRTA): Can the Stock Really Move This High?
2026-11-10 13:55 · Yahoo
Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates
2026-11-06 00:00 · Yahoo
Prothena: Q3 Earnings Snapshot
2026-11-05 22:32 · Yahoo
Prothena Reports Third Quarter 2026 Financial Results and Business Highlights
2026-11-05 21:05 · Yahoo
Prothena to Report Third Quarter 2026 Financial Results on November 5
2026-10-29 20:05 · Yahoo
Prothena's Partnership Strategy: Growth Driver or Limitation?
2026-10-20 15:34 · Yahoo
CRMD vs. PRTA: Which Stock Should Value Investors Buy Now?
2026-10-08 14:40 · Yahoo
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-09 20:05 · Yahoo
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
2026-08-06 23:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.